drug
vasopressin
Marketedupdated 3mo agoby Par Pharmaceutical Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying vasopressin
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 30, 2035
~8.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (49)
- Sep 27, 2044formulationUS 12447190
- Sep 27, 2044formulationUS 12447190
- Jan 30, 2035method-of-use (U-1857)US 10010575
- Jan 30, 2035method-of-use (U-1857)US 10010575
- Jan 30, 2035method-of-use (U-1857)US 10010575
- Jan 30, 2035method-of-use (U-1857)US 10010575
- Jan 30, 2035formulationUS 12186362
- Jan 30, 2035formulationUS 12186362
- Jan 30, 2035formulationUS 12186362
- Jan 30, 2035formulationUS 12186362
- Jan 30, 2035method-of-use (U-1857)US 9375478
- Jan 30, 2035method-of-use (U-1857)US 9375478
- Jan 30, 2035method-of-use (U-1857)US 9687526
- Jan 30, 2035method-of-use (U-1857)US 9687526
- Jan 30, 2035method-of-use (U-1857)US 9744209
- Jan 30, 2035method-of-use (U-1857)US 9744209
- Jan 30, 2035method-of-use (U-1857)US 9744239
- Jan 30, 2035method-of-use (U-1857)US 9744239
- Jan 30, 2035formulationUS 9750785
- Jan 30, 2035formulationUS 9750785
- Jan 30, 2035formulationUS 9919026
- Jan 30, 2035formulationUS 9919026
- Jan 30, 2035formulationUS 9919026
- Jan 30, 2035formulationUS 9919026
- Jan 30, 2035method-of-use (U-1857)US 9925233
- Jan 30, 2035method-of-use (U-1857)US 9925233
- Jan 30, 2035method-of-use (U-1857)US 9925233
- Jan 30, 2035method-of-use (U-1857)US 9925233
- Jan 30, 2035method-of-use (U-1857)US 9925234
- Jan 30, 2035method-of-use (U-1857)US 9925234
- Jan 30, 2035method-of-use (U-1857)US 9925234
- Jan 30, 2035method-of-use (U-1857)US 9925234
- Jan 30, 2035method-of-use (U-1857)US 9937223
- Jan 30, 2035method-of-use (U-1857)US 9962422
- Jan 30, 2035method-of-use (U-1857)US 9962422
- Jan 30, 2035method-of-use (U-1857)US 9962422
- Jan 30, 2035method-of-use (U-1857)US 9962422
- Jan 30, 2035method-of-use (U-1857)US 9968649
- Jan 30, 2035method-of-use (U-1857)US 9968649
- Jan 30, 2035method-of-use (U-1857)US 9968649
- Jan 30, 2035method-of-use (U-1857)US 9968649
- Jan 30, 2035method-of-use (U-1857)US 9974827
- Jan 30, 2035method-of-use (U-1857)US 9974827
- Jan 30, 2035method-of-use (U-1857)US 9974827
- Jan 30, 2035method-of-use (U-1857)US 9974827
- Jan 30, 2035method-of-use (U-1857)US 9981006
- Jan 30, 2035method-of-use (U-1857)US 9981006
- Jan 30, 2035method-of-use (U-1857)US 9981006
- Jan 30, 2035method-of-use (U-1857)US 9981006
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 37m ago
Found something off?
comments(0)
5-min edit window · permanent after that